Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Advanced Medical Solutions GroupCHIX:AMSL +0.09%83 Equity-to-Asset is 0.66 as of Dec. 2025, which is 21% below its 10-year median of 0.84. GuruFocus rates CHIX:AMSL with a GF Score™ of 83/100 and a GF Value™ of £3.73 (Modestly Undervalued). The stock has 8 warning signs investors should review. Among 853 Medical Devices & Instruments companies, Advanced Medical Solutions Group ranks better than 52.87% on this metric.
The historical rank and industry rank for Advanced Medical Solutions Group's Equity-to-Asset or its related term are showing as below:
CHIX:AMSl'
s Equity-to-Asset Range Over the Past 10 Years
Min: 0.62 Med: 0.84 Max: 0.87
Current: 0.66
During the past 13 years, the highest Equity to Asset Ratio of Advanced Medical Solutions Group was 0.87. The lowest was 0.62. And the median was 0.84.
CHIX:AMSl's Equity-to-Asset is ranked better than 52.87% of 853
companies
in the Medical Devices & Instruments industry
Industry Median: 0.64
vs CHIX:AMSl: 0.66
Advanced Medical Solutions Group (CHIX:AMSl) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Advanced Medical Solutions Group Equity-to-Asset Related Terms
Advanced Medical Solutions Group Equity-to-Asset Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Advanced Medical Solutions Group Equity-to-Asset Chart
CHIX:AMSL vs ISRG, BDX, MDLN: Equity-to-Asset Comparison
For the Medical Instruments & Supplies subindustry, Advanced Medical Solutions Group's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Advanced Medical Solutions Group Equity-to-Asset vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Advanced Medical Solutions Group's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Advanced Medical Solutions Group's Equity-to-Asset falls into.
Advanced Medical Solutions Group Equity-to-Asset Calculation
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Advanced Medical Solutions Group (CHIX:AMSL) has a Equity-to-Asset of 0.66 as of Dec. 2025. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Advanced Medical Solutions Group and its competitors. This is 21% below median its historical median of 0.84. Over the past decade, Advanced Medical Solutions Group's Equity-to-Asset has ranged from 0.62 to 0.87. According to the industry distribution chart, Advanced Medical Solutions Group ranks #402 out of 853 companies in the Medical Devices & Instruments industry, placing it in the top 47.1%.
Is Advanced Medical Solutions Group's Equity-to-Asset too high?
Advanced Medical Solutions Group's current Equity-to-Asset of 0.66 is 21% below median its 10-year median of 0.84. Over the past 10 years, this metric has ranged from a low of 0.62 to a high of 0.87. The Medical Devices & Instruments industry median Equity-to-Asset is 0.64. Advanced Medical Solutions Group's value of 0.66 is 3.1% above this industry median. Based on the distribution chart, Advanced Medical Solutions Group ranks #402 out of 853 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Advanced Medical Solutions Group has a GF Score™ of 83/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Advanced Medical Solutions Group's Equity-to-Asset compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Advanced Medical Solutions Group ranks #402 out of 853 companies for Equity-to-Asset. This puts Advanced Medical Solutions Group in the upper half of its industry. The industry median Equity-to-Asset is 0.64. Advanced Medical Solutions Group's value of 0.66 is 3.1% above this benchmark. Historically, Advanced Medical Solutions Group's own Equity-to-Asset has ranged from 0.62 to 0.87 over the past decade. While the company's 10-year median is 0.84 vs. the industry median of 0.64, Advanced Medical Solutions Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Medical Devices & Instruments company?
The median Equity-to-Asset among Medical Devices & Instruments companies is 0.64, based on 853 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Advanced Medical Solutions Group's current Equity-to-Asset of 0.66 is 3.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Advanced Medical Solutions Group and its competitors. For the Medical Devices & Instruments industry, the median Equity-to-Asset is 0.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Advanced Medical Solutions Group's current Equity-to-Asset is 0.66, which is 21% below median its own 10-year median of 0.84. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Advanced Medical Solutions Group stock overvalued right now?
Based on GuruFocus' analysis, Advanced Medical Solutions Group (CHIX:AMSL) is currently considered Modestly Undervalued. The stock's GF Value™ is £3.73, compared to a current price of £2.81 — trading 24.8% below its estimated fair value. The current Equity-to-Asset is 0.66, which is 21% below median its 10-year median of 0.84 and 3.1% above the Medical Devices & Instruments industry median of 0.64. Advanced Medical Solutions Group's overall GF Score™ is 83/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Advanced Medical Solutions Group (CHIX:AMSL), the current Equity-to-Asset is 0.66 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Advanced Medical Solutions Group (CHIX:AMSL) Overvalued in 2026?
Based on GuruFocus' analysis, Advanced Medical Solutions Group stock appears to be undervalued.
The current stock price of £2.81 is trading 24.8% below its estimated GF Value™ of £3.73.
GuruFocus considers Advanced Medical Solutions Group to be Modestly Undervalued.
Key valuation signals for CHIX:AMSL:
Equity-to-Asset: 0.66 (21% below median its 10-year median of 0.84)
GF Value™: £3.73 vs. price of £2.81 (24.8% below fair value)
Industry Position: 3.1% above the Medical Devices & Instruments median (#402 of 853)
No single metric tells the full story. See the CHIX:AMSL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Advanced Medical Solutions Group PLC is engaged in developing and manufacturing wound-care products for other healthcare manufacturers. AMS' key branded products include the ActivHeal franchise of hydrogel, hydrocolloid, foam, and alginate wound dressings. The firm also manufactures and markets a suite of branded products in surgical use, including the LiquiBand franchise for tissue adhesion and the Resorba line of sutures and collagen-based products for tissue repair. The company's segment includes: Surgical and Woundcare, of which the Surgical segment derives maximum revenue. Geographically, the company operates in the United Kingdom, Germany, France, the rest of Europe, the United States of America, and the rest of the world.
83GF Score
Get the complete analysis for CHIX:AMSL
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:AMSL has been successfully added to your 
